Product Program year 2025 Source: CMS Open Payments

Duramatrix

Device Neuro

PDI 00813954020181

Open in the dashboard

General payments

$71,192

955 payments

Research payments

$2,875

1 payment

Through program year 2025, $71,192 in general payments and $2,875 in research payments were reported against Duramatrix (Neuro).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $16,543 235
2024 General $22,688 265
2024 Research $2,875 1
2023 General $12,175 188
2022 General $8,813 152
2021 General $10,973 115

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $71,192 955 payments
Top recipients General payments · program year 2025
  1. U Of U Hospitals & Clinics Teaching hospital · UT $3,000 18% · 2 payments
  2. Walavan Sivakumar Neurological Surgery · Torrance, CA $600 4% · 1 payment
  3. Adam Kaufman Otology & Neurotology · Baltimore, MD $316 2% · 2 payments
  4. Natalie Justicz Otolaryngology · Ann Arbor, MI $316 2% · 2 payments
  5. Jorge Urquiaga Neurological Surgery · St. Louis, MO $285 2% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurological Surgery $6,628 61% · 102 practitioners
  2. Physician Assistant $1,426 13% · 31 practitioners
  3. Otolaryngology $653 6% · 4 practitioners
  4. Otology & Neurotology Otolaryngology $391 4% · 2 practitioners
  5. Nurse Practitioner, Acute Care Nurse Practitioner $257 2% · 6 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Utah $3,000 18% · 1 recipient
  2. Florida $1,710 10% · 27 recipients
  3. Missouri $1,551 9% · 24 recipients
  4. Ohio $1,344 8% · 13 recipients
  5. New York $1,104 7% · 11 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

955 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record